dc.contributor.author |
Lazova, Rossitza |
|
dc.contributor.author |
Seeley, Erin-H. |
|
dc.contributor.author |
Kutzner, Heinz |
|
dc.contributor.author |
Scolyer, Richard-A. |
|
dc.contributor.author |
Scott, Glynis |
|
dc.contributor.author |
Cerroni, Lorenzo |
|
dc.contributor.author |
Fried, Isabella |
|
dc.contributor.author |
Kozovska, Milena-E. |
|
dc.contributor.author |
Rosenberg, Arlene-S. |
|
dc.contributor.author |
Prieto, Victor-G. |
|
dc.contributor.author |
Shehata, Bahig-M. |
|
dc.contributor.author |
Durham, Megan-M. |
|
dc.contributor.author |
Henry, Gina |
|
dc.contributor.author |
Rodriguez-Peralto, Jose-L. |
|
dc.contributor.author |
Riveiro-Falkenbach, Erica |
|
dc.contributor.author |
Schaefer, Jochen-T. |
|
dc.contributor.author |
Danialan, Richard |
|
dc.contributor.author |
Fraitag, Sylvie |
|
dc.contributor.author |
Vollenweider-Roten, Sonja |
|
dc.contributor.author |
Sepehr, Alireza |
|
dc.contributor.author |
Sangueza, Martin |
|
dc.contributor.author |
Hijazi, Nouf |
|
dc.contributor.author |
Corredoira, Yamile |
|
dc.contributor.author |
Kowal, Rachel |
|
dc.contributor.author |
Harris, Olga-M. |
|
dc.contributor.author |
Bravo Puccio, Francisco Gerardo |
|
dc.contributor.author |
Boyd, Alan-S. |
|
dc.contributor.author |
Gueorguieva, Ralitza |
|
dc.contributor.author |
Caprioli, Richard-M. |
|
dc.date.accessioned |
2019-02-06T14:45:36Z |
|
dc.date.available |
2019-02-06T14:45:36Z |
|
dc.date.issued |
2016 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5099 |
|
dc.description.abstract |
BACKGROUND: Previously, using imaging mass spectrometry (IMS), we discovered proteomic differences between Spitz nevi and Spitzoid melanomas. OBJECTIVE: We sought to determine whether IMS can assist in the classification of diagnostically challenging atypical Spitzoid neoplasms (ASN), to compare and correlate the IMS and histopathological diagnoses with clinical behavior. METHODS: We conducted a retrospective collaborative study involving centers from 11 countries and 11 US institutions analyzing 102 ASNs by IMS. Patients were divided into clinical groups 1 to 4 representing best to worst clinical behavior. The association among IMS findings, histopathological diagnoses, and clinical groups was assessed. RESULTS: There was a strong association between a diagnosis of Spitzoid melanoma by IMS and lesions categorized as clinical groups 2, 3, and 4 (recurrence of disease, metastases, or death) compared with clinical group 1 (no recurrence or metastasis beyond a sentinel node) (P < .0001). Older age and greater tumor thickness were strongly associated with poorer outcome (P = .01). CONCLUSIONS: IMS diagnosis of ASN better predicted clinical outcome than histopathology. Diagnosis of Spitzoid melanoma by IMS was strongly associated with aggressive clinical behavior. IMS analysis using a proteomic signature may improve the diagnosis and prediction of outcome/risk stratification for patients with ASN. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Journal of the American Academy of Dermatology |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
atypical Spitzoid neoplasm |
en_US |
dc.subject |
histopathology |
en_US |
dc.subject |
imaging mass spectrometry |
en_US |
dc.subject |
mass spectrometry |
en_US |
dc.subject |
Mass Spectrometry |
en_US |
dc.subject |
Spitz nevus |
en_US |
dc.subject |
Spitzoid melanoma |
en_US |
dc.subject |
Adolescent |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Age Factors |
en_US |
dc.subject |
Aged |
en_US |
dc.subject |
Aged, 80 and over |
en_US |
dc.subject |
Child |
en_US |
dc.subject |
Child, Preschool |
en_US |
dc.subject |
Diagnosis, Differential |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Lymphatic Metastasis |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Melanoma/chemistry/diagnostic imaging/secondary |
en_US |
dc.subject |
Middle Aged |
en_US |
dc.subject |
Neoplasm Recurrence, Local/chemistry/diagnostic imaging/pathology |
en_US |
dc.subject |
Nevus, Epithelioid and Spindle Cell/chemistry/diagnostic imaging/pathology |
en_US |
dc.subject |
Proteins/analysis |
en_US |
dc.subject |
Retrospective Studies |
en_US |
dc.subject |
Risk Assessment |
en_US |
dc.subject |
Sentinel Lymph Node Biopsy |
en_US |
dc.subject |
Skin Neoplasms/chemistry/diagnostic imaging/pathology |
en_US |
dc.subject |
Treatment Outcome |
en_US |
dc.subject |
Tumor Burden |
en_US |
dc.subject |
Young Adult |
en_US |
dc.title |
Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.jaad.2016.07.007 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.15 |
|
dc.relation.issn |
1097-6787 |
|